Abstract. In the present work, an attempt has been made to screen Prosopis africana seed gum (PG), anionic polymer for extended release tablet formulation. Different categories of drugs (charge basis) like diclofenac sodium (DS), chlorpheniramine maleate (CPM), and ibuprofen (IB) were compacted with PG and compared with different polymers (charge basis) like xanthan gum (XG), hydroxypropyl methyl cellulose (HPMC-K100M), and chitosan (CP). For each drug, 12 batches of tablets were prepared by wet granulation technique, and granules were evaluated for flow properties, compressibility, and compactibility by Heckel and Leuenberger analysis, swelling index, in vitro dissolution studies, etc. It has been observed that granules of all batches showed acceptable flowability. According to Heckel and Leuenberger analysis, granules of PG-containing compacts showed similar and satisfactory compressibility and compactibility compared to granules of other polymers. PG showed significant swelling (P<0.05) compared to HPMC, and better than CP and XG. Differential scanning calorimetry (DSC), X-ray diffraction (XRD), and Fourier transform infrared (FTIR) study showed no interaction between drugs and polymers. From all PG-containing compacts of aforesaid drugs, drug release was sustained for 12 h following anomalous transport. Especially, polyelectrolyte complex formation retarded the release of oppositely charged drug (CPM-PG). However, extended release was noted in both anionic (DS) and nonionic (IB) drugs, maybe due to swollen gel. All compacts were found to be stable for 3-month period during stability study. This concludes that swelling and release retardation of PG has close resemblance to HPMC, so it can be used as extended release polymer for all types of drugs.
INTRODUCTION
In recent years, oral drug delivery has been known as the most expedient route, among all routes of drug administration (1) . Oral sustained release (SR) mode of drug administration is preferred over conventional dosage forms because of its assurance to impact the magnitude of the pharmacological response: (a) it minimizes fluctuation in blood drug concentrations; (b) it produces a slow input rate which tends to minimize the body's counteraction to the drug's intervening effect on regulated physiological processes; (c) it reduces the frequency of dosing; (d) it provides a continuous mode of drug administration; and (e) enhanced patient compliance (2) (3) (4) . Means, sustained delivery is meant to extend the drug release, consequently, therapeutic effect at a predetermined rate over a period of time (5) .
Because of the lower costs and ease of fabrication of different polymers, either hydrophobic such as Eudragit and ethyl cellulose (6) or hydrophilic such as hydroxylpropyl cellulose, hydroxylpropyl methyl cellulose (HPMC), and methylcellulose have been used for years to formulate SR formulations (7) (8) (9) . Literature reveals profound work which contributed in SR formulation design using natural polymers like xanthan gum (XG) (10) , guar gum (11) , chitosan (CP) (12) , okra gum (13) , and karaya gum (14, 15) . Oppositely charged natural polyelectrolytes like κ-carrageenan-chitosan, sodium alginate-chitosan, and poly(acrylic acid)-chitosan have also been utilized to retard the release of oppositely charged drugs (16) (17) (18) (19) (20) . Some of the lucrative characteristics of natural polymers make them useful for extended drug delivery purpose are biocompatibility, inexpensiveness, wide availability, compatibility with drugs, physiological inertness, etc. Even, natural polymers can also be modified to have tailor-made features meeting drug delivery system objectives and thus can compete with the synthetic biodegradable polymers available in the market (21) .
Keeping same in the view, the present work has been attempted to explore extended release application of Prosopis africana gum, obtained from a perennial leguminous tree of the subfamily Mimosoidae. It is a multipurpose tree of great economic value among the rural communities in the Guinea savanna of Nigeria (22) . The fruit of the tree is used as feed for animals (23) , while the seeds are fermented to make ukpehe, or "daddawa" cake, a highly pretentious condiment (24, 25) . Its various parts have been reported as a neutraceutical (26, 27) , therapeutic agent (28, 29) , and bioadhesive gum for pharmaceutical preparations (30, 31) . The traditional claim on use of gum of P. africana states its application in water purification. Basically, the seed coat of this plant possesses two polymers: inner hydrophilic (anionic) and outer lipophilic (cationic). In the present studies, inner hydrophilic coat has been powdered (PG), wet-granulated using model drugs (selected on charge basis) like diclofenac sodium (DS; anionic), chlorpheniramine maleate (CPM; cationic), and ibuprofen (IB; nonionic) and subjected to flowability, compressibility, compactibility, and in vitro dissolution studies.
MATERIALS AND METHODS

Materials
Ibuprofen, diclofenac sodium, and chlorpheniramine maleate were obtained as a gift sample from Block Pharma (Kolhapur, India), Cipla Pharmaceuticals (Mumbai, India), and Supriya Chemicals (Mumbai, India), respectively. P. africana seed gum was obtained as kind gift from Dr. Petra Nnamani (Nigeria). HPMC and XG were procured from Loba Chemie laboratory (Mumbai, India) and CP from Mahtani Chitosan Private Ltd. (Verval, India).
Methods
Preparation of P. africana Seed Gum (PG)
The PG gum used was prepared by method reported by Takada et al., with few modifications (30) . The P. africana seeds were procured from a local market in Nigeria and washed with water. Further seeds were sun-dried for several days and processed in attrition mill to separate the endosperm from husk. Inner part of seed coat was soaked in water for 24 h followed by cooking (5 h) in glass containers. The swollen mass was collected manually and allowed to soak in 0.1% w/v sodium metabisulfite aqueous solution for 24 h. Subsequently, material was homogenized using homogenizer. The highly viscous material obtained was passed through a Whatman filter paper no. 41 to remove any gritty particles, followed by precipitation of filtrate with twice the volume of acetone. The resultant precipitate was collected on a Buchner funnel by means of suction using a vacuum pump. The material was dried in a vacuum oven (to prevent auto-oxidation) for 24 h and pulverized using a mixer grinder. The powder samples were stored in tightly closed containers until used (30) .
Standardization of PG
Separated gum was further subject to preliminary chemical investigation using different chemical tests and thin-layer chromatography. PG was also subjected to Fourier transform infrared (FTIR) spectroscopy, powder X-ray diffraction (PXRD), and differential scanning calorimetry (DSC) analysis.
Preparation and Evaluation of Granules
Each polymer (PG, HPMC, XG, and CP) in amounts 10, 20, and 30% were wet-granulated with three drugs (IB, DS, and CPM) separately along with other excipients, and accordingly, 36 batches of the granules were prepared as given in Table I (batch size of 60 tablets) . Drug, polymer (10, 20 , and 30% w/w), and lactose monohydrate were dry-mixed for 5 min in mortar. Further, dry mix was moistened with an appropriate amount of granulating agent (polyvinyl pyrrolidone (PVP K30) solubilized in isopropyl alcohol) and wet-mixed for 5 min in same mortar. The wet mass was passed through sieve no. 20, and the granules were dried in a hot air oven (Sai Enterprises, Mumbai, India) for 1 h at 60°C. Dried granules were passed through sieve no. 20, followed by addition of magnesium stearate and talc. Eventually, prepared granules were subject to further studies.
Preparation of Blend for Direct Compression
All the ingredients as reported in Table I were taken and mixed for 10 min in mortar and subjected to direct compression.
Micromeritics
Bulk Density and Tap Density
Accurately weighed granules of mass M of all batches were transferred separately in 100-ml graduated cylinder. The volume occupied by each sample, before (Vb) and after tapping (Vt) were determined in triplicate using bulk density apparatus (Lab Hosp, Mumbai, Maharashtra, India). The bulk density (ρb) and tap density (ρt) was calculated using the following formulas (32, 33) :
Flowability Determination
Angle of Repose, Carr's Compressibility Index, and Hausner's Ratio
Flowability of granules of all batches were assessed by the angle of repose, determined in triplicate using fixed funnel free-standing cone method and was calculated using the following formula (32, 33) :
where θ is the angle of repose, H is the height between the lower tip of the funnel and the base of the heap of powder, and R is radius of the base of heap formed.
Granules of all batches were evaluated for Carr's compressibility index (CCI) and Hausner's ratio (HR) in triplicate and calculated using the following formula (32) (33) (34) :
where TD and BD are tapped density and bulk density, respectively.
Kawakita Analysis
The Kawakita equation is used for assessing the flow properties of powders. The flowability of the PG, direct compression mass, and granules was studied by Kawakita plot (35) . The reduction in volume of bed with tappings was noted using bulk density apparatus. The plot of number of tappings (n) versus the degree of volume reduction (n/c) was obtained, and the value of constants a and b was calculated by using the following equation (36) :
where n is the number of taps; a and b are constants, a describe the degree of volume reduction at the time of tapping and is called compactibility; 1/b is considered as constant of cohesion, and C is the degree of volume reduction and is given by equation as follows (37):
where V 0 is the initial volume before tapping and V ∞ is volume after tapping.
Compressibility and Compactibility
Homogeneous granulated powder mixtures were further compressed by hydraulic press using 8-mm flat-faced punch and die for DS, CPM, while IB was compressed using 13-mm flat-faced punch and die set at a pressure of 1.5 t for 1-min dwell time to produce compacts (different dies for compression were selected based upon final weight of tablet). Lubrication of the die and punches was carried out by 1% w/v dispersion of magnesium stearate in acetone. Formulation ingredients for each formulation are given in Table I .
Pressure-Relative Density Relationship
The pressure-relative density studies were performed according to the method reported by Heckel (38) . Matrices on compaction, after 24 h of relaxation, were subject to weight, diameter, and thickness measurements. Heckel study was done in triplicate for every batch. The data obtained were subject to Heckel equation:
where ρ r is the packing fraction of the tablet; P is the applied pressure in tons; and K y is the Heckel constant, K y =1/3σ 0 , where σ 0 is yield strength; and mean yield pressure (MyP) is equal to 3σ 0 . The constant A expresses densification at low pressure (39) .
Pressure-Tensile Strength (σt) Relationship
After determination of the diameter (D) and thickness (t), the matrices used for compression study were subject to determination of the force (F) required to breaking the compacts (hardness) by a Monsanto-type hardness tester (Lab Hosp, Mumbai, India), and the data were subjected to tensile strength (σ t ) determination by using following equation (40):
where D is the diameter, t is the thickness of compacts, and F is the force required to break the compacts.
Leuenberger Analysis
Compression susceptibility (γ) and compactibility (σ tmax ) of compact were assessed from Leuenberger analysis. The data of pressure, relative density, and tensile strength was subject to nonlinear regression equation as follows (41):
where P is the pressure and rd is the relative density.
Swelling Index
The extent of swelling was measured in terms of % weight gain by the tablet. One tablet from each formulation was kept in a Petri dish containing phosphate buffer pH 6.8. At the end of 1 h, the tablet was withdrawn, kept on tissue paper and weighed. The procedure was repeated till 12 h, and % weight gain by the tablet was calculated by following equation (42):
where M t =weight of tablet at time (t) and M 0 =weight of tablet at time t=0.
Fourier Transform Infrared Spectroscopy
FTIR spectra of purified drugs were recorded using an infrared spectrophotometer (Jasco V-730). About 2 mg of sample was ground thoroughly with KBr; uniformly mixed sample was kept in sample holder, and a spectrum was recorded over the wave number 400-4000 cm −1 .
Powder X-Ray Diffraction
Crystallinity of the drugs and excipients was analyzed by PXRD study. The sample was irradiated with monochromatic Cu Kα radiation (1.742Ǻ) between 7°and 77°(using 2 h) on Xray diffractometer (Philips analytical XRD, PW 3710). The voltage and current applied were 40 kVand 30 mA, respectively.
Differential Scanning Calorimetry
Thermal behavior of the drug and excipients was analyzed by DSC. Shimadzu DSC (TA instruments, model SDT 2960, USA) equipped with intracooler and refrigerated cooling system was used to analyze the sample. Samples were kept in aluminum crucibles, prior to heating under nitrogen flow (50 ml min −1 ) at a scanning rate of 10°C min −1 . Aluminum crucible devoid of sample was used as reference.
In Vitro Drug Release Studies
Compacts were subject to drug release studies (n=3) in USP type II dissolution test apparatus (TDT-08L, Electrolab, Mumbai, India) in 900 ml of 0.1 N HCl for the first 2 h, followed by phosphate buffer (pH 6.8) for the rest hours (37 ±0.5°C and 100 rpm) for all drugs. Five-milliliter aliquots were withdrawn for analysis and replenished by equivalent amount of blank. The aliquots were filtered through Whatman filter paper no. 41 and further analyzed at respective wavelength by double-beam UV-visible spectrophotometer (Jasco V-530). The data obtained were fed in PCP Disso V 3.0 (Pune, India) software to type the drug release kinetics. Observed values of dissolution data of PG (test) batches and other polymers (reference) formulations were used for calculation of similarity factor (ƒ2) (PCP Disso V 3.0 Pune, India).
Accelerated Stability Study
Accelerated stability studies (ICH Q1A (R2)) were conducted for 3-month period at temperature of 40±2°C and 75± 5% RH to assess the stability of all compacts with respect to their drug release characteristics. Sampling was done at the end of 1, 2, and 3 months (43). 
RESULT AND DISCUSSION
Thirty-six batches having each polymer (PG, HPMC, XG, and CP) in an amount of 10, 20, and 30% along with drugs have been successfully prepared.
Standardization of PG
Gum is abundant source of carbohydrates and made up of highly branched polysaccharides formed due to condensation of monosaccharides with elimination of water molecule(s). Thin-layer chromatography revealed presence of glucose, fructose, and galactose. The results of FTIR, PXRD, and DSC have been discussed subsequently.
Micromeritics
Bulk Density and Tap Density
Bulk density and tap density was found to be satisfactory in the range of 0.681-0.768 and 0.703-0.860 g ml −1 , respectively. Noteworthy, improvement in the flow rate of direct compression blend and granules has been observed, which may be attributed to interparticulate interaction as it directly influence bulk density of a powder and its flow (44). Similarly, increased tapped density for granules and direct compression blend indicated better degree of compactibility as a function of applied pressure (45, 46) .
Flowability Determination
Angle of Repose (θ), Carr's Compressibility Index, and Hausner's Ratio 
Kawakita Analysis
Linear relationship has been observed in Kawakita plot for PG, direct compression blends, and granules of all drugs. Study revealed that granules attended the final packing state unhurriedly may be due to presence of void spaces and initial fragmentation at lower pressure. Lower value of a (0.808-0.898) than b (6.07-12.52) indicates the better flowability of granules compared to direct compression blend. Noteworthy, granules were found to be more cohesive than direct compression blend, and it was attributed to higher 1/b value (47).
Compressibility and Compactibility
Pressure-Relative Density Relationship
Heckel plot (Fig. 1) reveals no linearity at initial stages of compression for direct compression formulations and granules of all three drugs (DS, CPM, and IB), due to particle rearrangement at early stage of compression, i.e., at low pressure (47, 48) . Higher value of A for granules of all drugs as compare to PG and direct compression formulation indicates higher degree of fragmentation which may be attributed to larger particle size of granules. Another reason for higher fragmentation might be presence of high-fragmenting material, i.e., lactose monohydrate in formulation (49) . Granules for all drugs showed plastic deformation when the compression pressure was increased (50) . Moreover, at higher pressure, rate of densification was higher due to reduction in void spaces between particles (51) .
MyP values obtained from Heckel equation for granules of DS, CPM, and IB are reported in Tables II, III, and IV respectively. For all drugs (DS, CPM, and IB) a trend of MyP value reduction was observed with decrease in concentration 
Pressure-Tensile Strength (σt) Relationship
Tensile strength is an important aspect which will impact on compactibility of the material. Increased tensile strength of granules was noted as compared to direct compression blend. This might have been due to its higher tendency to create clean surfaces throughout compaction causing reduction in the contamination with lubricants such as magnesium stearate and eventually increase in the tensile strength of the tablets produced (52, 53) . It was observed that, with increase in concentration of PG, tensile strength got reduced for all batches (Tables II, III, and IV) . At low concentration, PG particles might have been performed role as void filler and contributed in better rearrangement during the compression. At higher concentration of PG, difference in the particle size created the more void space causing poor compressibility and reduced tensile strength. Although the tensile strength of tablet prepared using PG is less as compared to other marketed polymers, it is still satisfactory. The reason may be the difference in particle size of gum.
Leuenberger Analysis
The parameter σ tmax and γ allocate a characterization of the different materials (54) . Lower value of γ for PG demonstrated that maximum crushing strength might be obtained at higher compression pressure unlike granules and direct compression formulation of all drugs, while higher value of γ for compact formed by direct compression and wet granulation technique indicates that the σ tmax is reached more quickly at lower pressures of compression. Granules of all drugs can fabricate a compact with a higher strength than direct compression formulation, attributed to higher σ tmax value for granules than direct compression formulation.
In our study, value of σ tmax for all compacts was found to be in the range of 0.85-1.90, while γ was in the range of 1.8-5.3. In the case of all granules, increasing pressure of compression has not affected the crushing strength remarkably. This indicates the capping propensity of the material at higher pressure due to different internal tensions generated during the process.
Swelling Index
At the end of 12 h, compacts containing DS, CPM, and IB shows about 61.17±0.113, 59.03±0.065, and 55.147±0.014% swelling, respectively. This swelling index or water holding capacity was less compared to HPMC which shows 78.66±0.563 swelling. This swelling behavior and formation of gel-like structure was the main contributing mechanism. Swelling action of PG, in turn, is controlled by the rate of water uptake into the compacts (Fig. 2) . Swelling behavior of all batches used in the study was found to be significant (P<0.05). Swelling of PG showed close resemblance to the swelling behavior of HPMC which is a model polymer having magnificent swelling (55) .
Fourier Transform Infrared Spectroscopy Study
FTIR spectra of PG (Fig. 3) has shown three characteristic peaks related to CH 3 -Co-group, -C-(CH 3 ) 2 , and C-N Powder X-Ray Diffraction Study PXRD spectra of PG, DS, CPM, IB, and their physical mixtures are shown in Fig. 4 . No diffraction peak is observed in PXRD spectra of PG except a single less intense peak at around 28°. Intensity of this peak is low, so it indicates amorphous nature of gum. Strong diffraction peaks observed in PXRD spectra of DS, CPM, and IB indicate their crystalline nature. Similarly, physical mixtures of all drugs also showed some diffraction peaks but of reduced intensity. So, from the PXRD study, it will be concluded that there is very less reduction in intensity of peaks so crystallinity also reduced in small extent.
Differential Scanning Calorimetry Study Analysis
The DSC thermogram of PG, DS, CPM, IB, and their physical mixtures are shown in Fig. 5 . The DSC thermogram of PG shows an endothermic peak at 150.35°C, corresponding to melting point of gum. Thermogram of DS plain drug has shown endothermic peak at 58.23 and 285.28°C which can be attributed to moisture and melting point, respectively, while in case of physical mixture, minute shifting of peaks are observed at 72.58 and 266.86°C. So, no any incompatible thermal changes were reported in thermogram. However, PG is of large molecular weight polymer, so one or more components may get melted in this range which gives endothermic peaks in DSPM. So, there may be some possibility of interaction in between drug and gum. Thermogram of CPM shows endothermic peaks at 133°C and broad peak at 105°C which can be assigned to melting point and glass transition temperature of CPM, respectively. In physical mixture, peaks were reported at 108.6°C, while broadening of peak at 150.2°C may be due to overlapping of melting of drug and PG. Peaks at 202.9 and 215.9°C may be due to melting of lactose; this type of result may be due to some interactions between drug and polymer. Thermogram of IB shows endothermic peak at 72°C, which corresponds to its melting point. In case of physical mixture, peaks have been observed at 73.6, 150.7, and 215.9°C. The first and second peaks correspond to melting point of IB and PG, respectively, while the third peak may be attributed to melting of lactose monohydrate. Presence of endothermic peak at respective meting point of drug in physical mixture is attributed to occurrence of drug in crystalline state (57) . 
In Vitro Drug Release Studies
When oppositely charged drug is dispersed in a PG polymer, being anionic polymer, it forms drug-polyelectrolyte complex which affects drug release. In addition to this, when PG comes into contact with water, it swells and forms a viscous gel-type network. Owing to rapid gelification matrix gets hydrated instead of disintegration. Slow matrix erosion via formation of fronts may also contribute to the extended release application of PG. All the formulations were found to be swollen and maintained their integrity throughout the 12-h study; only surface erosion phenomenon with rounded off or smoothed edges was observed.
In vitro release studies on compacts showed dependency of drug release on concentration of polymer added irrespective of charge on drug. For all drugs, approximately same pattern of release was observed from compacts containing PG and HPMC. Percent release of all batches at the end of 12 h and their release kinetic models are shown in Table V . Plot of % cumulative drug release Vs time for DS, CPM, and IB are shown in Figs. 6, 7, and 8, respectively.
Value of ƒ2 between all batches was found to be more than 50, so it is similar in release pattern of other polymers (HPMC, XG, and CP) except for batches of DS-CP1 (44.17) . Observed value of ƒ2 in between IB-PG1: IB-XG1 (99.53), IB-PG1: IB-CP1 (98.06), and IB-PG1: IB-HPMC1 (93.26) batches shows the close resemblance between release pattern of PG with HPMC, XG, and CP (Table VI) . So, it indicates the release retarding ability of PG similar to marketed polymers.
Accelerated Stability Study
In case of DS-PG3, CPM-PG3, and IB-PG3 compacts, drug release was found to be in the range of 62-68, 56-63, and 49-56%, respectively, following zero order, Higuchi matrix, and Higuchi matrix model, respectively (Fig. 9) . So, it was observed that with time, the release retarding principle was found to be active, so these compacts were found to be suitable in 3-month period of stability study without causing any incompatible changes in formulation.
CONCLUSION
Compacts of aforediscussed drugs, P. africana and other polymers were successfully prepared and evaluated for extended release. It has been observed that P. africana has satisfactory compressibility and compactibility as that of rest all polymers under investigation. Interestingly, increase in MyP with increase in amount of PG was noted in granules unlike other polymers. As anticipated, release of drug from all polyelectrolyte complexes were dependent on amount of polymer added. Release was extended longer with increased amount of polymer in compact. It was interesting to note that extent and pattern of release of PG lies close to HPMC. The role of electrostatic interactions has been demonstrated as expected. This concludes that the P. africana seed gum can be a very good addition to the plethora of existing natural polymers used in controlled drug delivery, and it will be plausibly economical concern for pharmaceutical industries to use this polymer.
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